Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Braz J Anesthesiol ; 63(2): 202-8, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23601262

RESUMO

BACKGROUND AND OBJECTIVES: In our study we aimed to investigate the effect of bupivacaine and levobupivacaine on QT, corrected QT (QTc), and P wave dispersion durations during spinal anesthesia in cesarean section. METHODS: Sixty parturients scheduled for elective cesarean section in ASA I-II risk groups were included in the study. Baseline electrocardiographic (ECG) records of the patients were obtained in the operation room. Heart rate (HR), non-invasive blood pressure (NIBP), peripheral oxygen saturation (SpO2) and respiration rates (RR) were recorded. Venous cannulation was performed with 18G cannula and fl uid preload made with 10mL.kg(-1). Lactated Ringer solution. After fl uid preload, second ECG recordings were taken and the patients were randomly separated into two groups. Group B (n=30) received 10mg of bupivacaine and Group L (n=30) received 10mg of levobupivacaine for spinal anesthesia. ECG recordings were repeated at 1, 5 and 10minutes after spinal block. HR, NIBP, SpO2 , RR and sensory block levels were also recorded at the same time intervals. At predetermined time intervals of spinal anesthesia, P wave dispersion (Pwd), QT dispersion (QTd), and QTc dispersion (QTcd) durations were measured from ECG records. QT and QTc durations are calculated with Bazzett formula.


Assuntos
Anestesia Obstétrica , Raquianestesia , Anestésicos Locais/farmacologia , Bupivacaína/farmacologia , Cesárea , Eletrocardiografia/efeitos dos fármacos , Adulto , Bupivacaína/análogos & derivados , Método Duplo-Cego , Feminino , Humanos , Levobupivacaína , Gravidez , Estudos Prospectivos
2.
Rev. bras. anestesiol ; 63(2): 202-208, mar.-abr. 2013. tab
Artigo em Português | LILACS | ID: lil-671562

RESUMO

OBJETIVOS E JUSTIFICATIVA: Nosso estudo teve como objetivo investigar o efeito de bupivacaína e levobupivacaína na duração das dispersões do QT, QT corrigido (QTc) e da onda P durante raquianestesia em cesariana. MÉTODOS: Sessenta parturientes programadas para cesariana eletiva ASA I-II foram incluídas no estudo. Exames eletrocardiográficos (ECG) foram feitos após a entrada das pacientes na sala de operação. Frequência cardíaca (FC), pressão arterial não invasiva (PANI), saturação periférica de oxigênio (SpO2) e frequência respiratória (RR) foram registradas. Para o acesso venoso, uma cânula de calibre 18G foi usada. A pré-carga de líquidos foi feita com solução de Ringer com lactato (10 mL.kg-1). Após a pré-carga de líquidos, um segundo exame eletrocardiográfico foi feito e as pacientes foram designadas aleatoriamente para dois grupos. O Grupo B (n = 30) recebeu 10 mg de bupivacaína e o Grupo L (n = 30) recebeu 10 mg de levobupivacaína para raquianestesia. Exames ECG foram repetidos nos minutos um, cinco e 10 após a anestesia. FC, PANI, SpO2, FR e os níveis de bloqueio sensorial também foram registrados nos mesmos intervalos de tempo. Em intervalos de tempo pré-determinados de raquianestesia, as durações da dispersão da onda P (OPd), QT (QTd) e QTc (QTcd) foram medidas a partir dos registros do ECG. As durações de QT e QTc foram calculadas com a fórmula de Bazzett. RESULTADOS: Não houve diferença entre os dois grupos quanto aos níveis de bloqueio, parâmetros hemodinâmicos, OPd, QTd, QTc e QTcd. CONCLUSÃO: Levobupivacaína e bupivacaína podem ser os anestésicos de escolha para raquianestesia em grávidas com dispersões prolongadas da OPd e QTcd no período pré-operatório.


BACKGROUND AND OBJECTIVES: In our study we aimed to investigate the effect of bupivacaine and levobupivacaine on QT, corrected QT (QTc), and P wave dispersion durations during spinal anesthesia in cesarean section. METHODS: Sixty parturients scheduled for elective cesarean section in ASA I-II risk groups were included in the study. Baseline electrocardiographic (ECG) records of the patients were obtained in the operation room. Heart rate (HR), non-invasive blood pressure (NIBP), peripheral oxygen saturation (SpO2) and respiration rates (RR) were recorded. Venous cannulation was performed with 18G cannula and fluid preload made with 10 mL.kg-1. Lactated Ringer solution. After fluid preload, second ECG recordings were taken and the patients were randomly separated into two groups. Group B (n = 30) received 10 mg of bupivacaine and Group L (n = 30) received 10 mg of levobupivacaine for spinal anesthesia. ECG recordings were repeated at 1, 5 and 10 minutes after spinal block. HR, NIBP, SpO2 , RR and sensory block levels were also recorded at the same time intervals. At predetermined time intervals of spinal anesthesia, P wave dispersion (Pwd), QT dispersion (QTd), and QTc dispersion (QTcd) durations were measured from ECG records. QT and QTc durations are calculated with Bazzett formula. RESULTS: There was no difference between two groups according to block levels, hemodynamic parameters, Pwd, QTd, QTc and QTcd durations. CONCLUSION: Bupivacaine and levobupivacaine may be preferred in spinal anesthesia in pregnant patients who have extended Pwd and QTcd preoperatively.


OBJETIVOS Y JUSTIFICATIVA: Nuestro estudio tuvo como objetivo investigar el efecto de la bupivacaína y la levobupivacaína en la duración de las dispersiones del QT, QT corregido (QTc) y de la onda P durante la raquianestesia en cesárea. MÉTODOS: Sesenta parturientes programadas para cesárea electiva en grupos de riesgo ASA I-II fueron incluidas en el estudio. Los exámenes electrocardiográficos (ECG) se hicieron después de la entrada de las pacientes al quirófano. Se registraron la frecuencia cardíaca (FC), presión arterial no invasiva (PANI), saturación periférica de oxígeno (SpO2) y frecuencia respiratoria (RR). Para el acceso venoso, se usó una cánula de calibre 18. La precarga de líquidos fue hecha con una solución de Ringer con lactato (10 mL.kg-1). Después de la precarga de líquidos, un segundo examen electrocardiográfico se hizo y las pacientes fueron designadas aleatoriamente para dos grupos. El Grupo B (n = 30) recibió 10 mg de bupivacaína y el Grupo L (n = 30) recibió 10 mg de levobupivacaína para la raquianestesia. Los exámenes ECG se repitieron en los minutos 1, 5 y 10 después de la anestesia. FC, PANI, SpO2, FR y los niveles de bloqueo sensorial también fueron registrados en los mismos intervalos de tiempo. En intervalos de tiempo predeterminados de raquianestesia, las duraciones de la dispersión de la onda P (OPd), QT (QTd) y QTc (QTcd) fueron medidas a partir de los registros del ECG. Las duraciones de QT y QTc fueron calculadas con la fórmula de Bazzett. RESULTADOS: No hubo diferencia entre los dos grupos en cuanto a los niveles de bloqueo, parámetros hemodinámicos, OPd, QTd, QTc y QTcd. CONCLUSIONES: La levobupivacaína y la bupivacaína pueden ser los anestésicos de elección para la raquianestesia en las embarazadas con dispersiones prolongadas de la OPd y QTcd en el período preoperatorio.


Assuntos
Adulto , Feminino , Humanos , Gravidez , Anestesia Obstétrica , Raquianestesia , Anestésicos Locais/farmacologia , Bupivacaína/farmacologia , Cesárea , Eletrocardiografia/efeitos dos fármacos , Bupivacaína/análogos & derivados , Método Duplo-Cego , Estudos Prospectivos
3.
Kaohsiung J Med Sci ; 29(2): 75-81, 2013 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-23347808

RESUMO

Ischemia reperfusion injury causes the release of free oxygen radicals. Free oxygen radicals initiate the production of toxic metabolites, such as malondialdehyde (MDA), through the lipid peroxidation of cellular membranes. Following lipid peroxidation, the antioxidant enzyme system is activated against reactive oxygen species (ROS) and attempts to protect cells from oxidative damage. There is a balance between the scavenging capacity of antioxidant enzymes and ROS. Because of this balance, the total antioxidant capacity (TAC) measurement is a sensitive indicator of the overall protective effects of the antioxidants. Alpha(2) receptor agonists are effective in preventing hemodynamic reactions during extremity surgeries by preventing the release of catecholamines secondary to tourniquet application. They have also been shown to possess preventive effects in various ischemia-reperfusion injury models. In our study, we examined the effects of dexmedetomidine on tourniquet-induced ischemia-reperfusion injury in lower extremity surgeries performed under general anesthesia. The effects of dexmedetomidine were measured with serum MDA and TAC levels. We studied 60 adult American Society of Anesthesiologists (ASA) physical status I or II patients undergoing one-sided lower extremity surgery with tourniquet. The patients were randomly divided into two groups. Group D was administered a dexmedetomidine infusion at a rate of 0.1µg/kg/minute(-1) for 10 minutes prior to induction and then at 0.7µg/kg/hour(-1) until 10 minutes before the end of the operation. The control group (Group C) received a saline infusion of the same amount and for the same period of time. General anesthesia was induced with thiopental, fentanyl, and rocuronium and maintained with nitrous oxide and sevoflurane in both groups. Venous blood samples were obtained before the administration of the study drugs (basal) at 1 minute before tourniquet release and at 5 and 20 minutes after tourniquet release (ATR). In both groups, MDA levels decreased at 5 and 20 minutes ATR when compared with the basal values (p<0.05). TAC levels decreased at 1 and 5 minutes ATR and then returned to basal values at 20 minutes ATR (p<0.05). In reference to the prevention of lipid peroxidation in tourniquet-induced ischemia-reperfusion injury, the results from the two groups in our study showed that dexmedetomidine did not have an additional protective role during routine general anesthesia.


Assuntos
Agonistas de Receptores Adrenérgicos alfa 2/farmacologia , Anestesia Geral , Dexmedetomidina/farmacologia , Extremidade Inferior/cirurgia , Traumatismo por Reperfusão/sangue , Torniquetes/efeitos adversos , Adolescente , Adulto , Idoso , Antioxidantes/análise , Esquema de Medicação , Feminino , Humanos , Peroxidação de Lipídeos/efeitos dos fármacos , Extremidade Inferior/irrigação sanguínea , Masculino , Malondialdeído/sangue , Pessoa de Meia-Idade , Estresse Oxidativo/efeitos dos fármacos , Traumatismo por Reperfusão/tratamento farmacológico , Traumatismo por Reperfusão/etiologia
4.
Braz J Anesthesiol ; 63(2): 202-8, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-24565127

RESUMO

BACKGROUND AND OBJECTIVES: In our study we aimed to investigate the effect of bupivacaine and levobupivacaine on QT, corrected QT (QTc), and P wave dispersion durations during spinal anesthesia in cesarean section. METHODS: Sixty parturients scheduled for elective cesarean section in ASA I-II risk groups were included in the study. Baseline electrocardiographic (ECG) records of the patients were obtained in the operation room. Heart rate (HR), non-invasive blood pressure (NIBP), peripheral oxygen saturation (SpO2) and respiration rates (RR) were recorded. Venous cannulation was performed with 18G cannula and fluid preload made with 10 mL.kg(-1). Lactated Ringer solution. After fluid preload, second ECG recordings were taken and the patients were randomly separated into two groups. Group B (n = 30) received 10mg of bupivacaine and Group L (n = 30) received 10mg of levobupivacaine for spinal anesthesia. ECG recordings were repeated at 1, 5 and 10 minutes after spinal block. HR, NIBP, SpO2, RR and sensory block levels were also recorded at the same time intervals. At predetermined time intervals of spinal anesthesia, P wave dispersion (Pwd), QT dispersion (QTd), and QTc dispersion (QTcd) durations were measured from ECG records. QT and QTc durations are calculated with Bazzett formula. RESULTS: There was no difference between two groups according to block levels, hemodynamic parameters, Pwd, QTd, QTc and QTcd durations. CONCLUSION: Bupivacaine and levobupivacaine may be preferred in spinal anesthesia in pregnant patients who have extended Pwd and QTcd preoperatively.


Assuntos
Anestésicos Locais/farmacologia , Bupivacaína/análogos & derivados , Bupivacaína/farmacologia , Cesárea , Eletrocardiografia/efeitos dos fármacos , Adulto , Raquianestesia , Feminino , Humanos , Levobupivacaína , Pessoa de Meia-Idade , Gravidez , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...